Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan
Tsung‐Hui Hu(National Sun Yat-sen University), Shih-Chung Chen(Ministry of Health and Welfare), Yang‐Yuan Chen(MingDao University), Shiou-Shiang Chen(Changhua County Public Health Bureau), Yen‐Po Yeh(National Taiwan University), Yu-Yu Tsao(Changhua County Public Health Bureau), Kwei‐Ming Chen(Chang Bing Show Chwan Memorial Hospital), Wei‐Wen Su(Taichung Veterans General Hospital), Sheng‐Lei Yan(Chang Bing Show Chwan Memorial Hospital), Chih‐Chao Yang(Ministry of Health and Welfare), Cherng Harng Lim(Changhua Christian Hospital), Yung‐Hsiang Yeh(Chang Bing Show Chwan Memorial Hospital), Chih-Da Yao(Changhua Christian Hospital), Chi‐Chieh Yang(Chang Bing Show Chwan Memorial Hospital), Sam Li‐Sheng Chen(Taipei Medical University), Jun-Hung Lai(Changhua Christian Hospital), W-Hsien Kuo
Cited by 39
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536